Mission & Milestones
Our mission is to make injectable medicines and vaccines safe and accessible to everyone. And every pharma company, contract manufacturer, healthcare provider, and nation we work with, helps bring us one step closer to that goal.
Company Fact Sheet
ApiJect is a medical technology company that seeks to improve how companies fill-finish injectable medicines. We work with pharma partners to design drug delivery systems, and assist in manufacturing those devices at their facilities or a trusted CMO/CDMO.
Together, the ApiJect Team of Executives and Industry Experts design and manufacture drug delivery systems to improve how sterile liquid medicines and vaccines are fill-finished across the world
View the solutions and results our team of Experts has delivered to achieve our customer’s goals and objectives.
These brand guidelines help the company communicate with a consistent look, feel, and tone. For any questions about guidelines or messaging, please contact firstname.lastname@example.org.
Read selected articles about ApiJect and our experts in the media.
We are ApiJect
We are a team of passionate and dedicated people. Our mission is to make injectable medicines and vaccines safe and accessible to everyone.
Awards & Recognition
Our company has been recognized and awarded for our Platform technology and innovation.
Sign up for our Newsletter…Coming Soon
ApiJect Systems, Corp., is a public-benefit medical technology company working to use our platform to bring more prefilled, single-dose injections to patients everywhere.
The ApiJect Platform enables pharmaceutical and biotech companies to design scalable prefilled injectors and efficiently fill-finish them with their injectable drug products. This can be done either on one of their own Blow-Fill-Seal packaging lines with ApiJect-licensed technology, or at one of ApiJect’s world-class manufacturing partners.
ApiLabs, R&D sister company to ApiJect, launches its Field Research Network
ApiJect Systems Announces Investment by Royalty Pharma and Jefferies
ApiJect Announces Roseanne Hofmann, PhD, MBA as New Chief Pharmaceutical Sciences Officer